On August 24, 2026, Core Scientific Inc CORZ shares fell 3.0% to a current price of $17.27, situated between a 52-week high of $30.46 and a low of $13.14. The decline reflects broader trends in the stock's performance, with a 1-week drop of 14.2% and a 1-month decline of 24.1%.
- GF Valueâ„¢ verdict: Current price of $17.27 vs GF Value of $11.49, indicating a 50.3% overvaluation.
- GF Scoreâ„¢: 47/100 (Average), suggesting a mixed evaluation of the company's overall health.
- Notable signal: Insider activity shows net selling of $4.4M over the past year, indicating potential concerns from insiders.
Is CORZ Overvalued or Undervalued?
The current GF Valueâ„¢ estimate of $11.49 suggests that Core Scientific Inc CORZ is significantly overvalued at its current price of $17.27. GF Valueâ„¢ is GuruFocus' proprietary intrinsic value estimate, which considers historical trading multiples, business growth patterns, and future performance projections. With a valuation label of "Significantly Overvalued," this indicates a substantial margin of safety is absent for potential investors. The 50.3% overvaluation poses a risk for investors as the price may need to adjust downward to align with its intrinsic value.
Given that CORZ is an unprofitable and cash-flow-negative company, traditional earnings-based valuation metrics like Price-to-Earnings (P/E) are not applicable. Instead, a Price-to-Sales (P/S) analysis, considering its historical median P/S of approximately 7.3x, may provide a more insightful comparison for assessing its current valuation. A sustained trading level above its historical median could indicate investor optimism, but without underlying profit generation, this optimism may be unfounded.
How Does CORZ's Valuation Compare to Its History?
| Metric | Current | Historical |
|---|---|---|
| P/E (TTM) | 816.2x | 26.4x |
Currently, CORZ's trailing twelve months (TTM) P/E ratio of 816.2x is drastically above its 5-year median of 26.4x, indicating a significant deviation from its historical valuation norms. This stark difference aligns with the GF Valueâ„¢ conclusion of being overvalued, reinforcing the notion that the current pricing does not reflect the company's historical earnings performance.
What Does CORZ's GF Scoreâ„¢ Tell Us?
The GF Scoreâ„¢ evaluates a company's financial strength, profitability, growth potential, valuation, and momentum. With a score of 47/100, CORZ is rated as average overall, but it exhibits weaknesses in financial strength and valuation metrics.
| Metric | Rating |
|---|---|
| GF Scoreâ„¢ | 47 |
| Financial Strength | 2/10 |
| Profitability | 4/10 |
| Growth | 9/10 |
| Valuation | 3/10 |
| Momentum | 0/10 |
The scores indicate that while CORZ shows strong growth potential (9/10), it suffers from considerable weaknesses in financial strength (2/10) and valuation (3/10). The lack of positive momentum (0/10) also raises concerns about the stock's sustainability in the near term.
What Are Gurus and Insiders Doing with CORZ?
Currently, 8 gurus hold Core Scientific Inc CORZ, with 5 increasing their positions and 5 trimming them in recent quarters. This suggests a mixed sentiment among institutional investors regarding the stock's future prospects.
In terms of insider activity, there has been net selling amounting to $4.4M over the past year, with insiders buying $0.3M and selling $4.7M. This pattern indicates a lack of confidence from insiders regarding the company's trajectory. Such selling may reflect concerns about the company's valuation and performance, which is a critical factor for potential investors to consider.
What This Means for Investors
Based on the analysis, Core Scientific Inc CORZ is currently overvalued, as indicated by the GF Valueâ„¢ estimate compared to its market price. The lack of profitability, high valuation multiples, and insider selling suggest caution for potential investors. Maintaining awareness of these factors is essential as the market navigates through evolving conditions.
For more detailed insights on Core Scientific Inc CORZ, visit the Core Scientific Inc (CORZ) stock page, or explore the GF Valueâ„¢ page for further valuation information.
Frequently Asked Questions
What is CORZ's GF Scoreâ„¢?
The GF Scoreâ„¢ for Core Scientific Inc CORZ is 47/100, which indicates an average evaluation of the company's overall financial health and potential.
Is CORZ overvalued or undervalued?
Core Scientific Inc CORZ is currently overvalued, with a GF Valueâ„¢ estimate of $11.49 compared to the market price of $17.27.
What is CORZ's P/E ratio?
The trailing twelve months (TTM) P/E ratio for CORZ is 816.2x, significantly above its historical median of 26.4x, indicating a stark overvaluation based on earnings performance.
This stock alert was generated using automated technology and GuruFocus financial data to provide readers with timely and accurate market reporting. This content was reviewed by GuruFocus editorial team prior to publication. Please send any questions or comments about this story to [email protected].
